期刊文献+

血管内皮生长因子基因的表达及血管生成作用 被引量:6

The Expression and angiogenesis Effect of VEGF gene
下载PDF
导出
摘要 构建新的血管内皮生长因子(VEGF)高效真核表达载体pcD 2 /VEGF, 体外转染VSMC 发现其在VSMC中的表达效率较 pcDNA 3 /VEGF 明显增高,体外和体内实验证实VEGF 基因具有显著促进血管生成的作用。 To study the expression and its angiogenesis effect of VEGF gene The human VEGF cDNA was cloned into eukaryotic expression vector pcD2 The recombinant plasmids were transfected into VSMC and bygene suture transferred into the adductor of rats of which the distal extreme of external iliac artery weere ligated With ELISA immunohistochemistry and alkaline phosphotase staining we investigated the in vitro and in vivo expression and its angiogenesis effect of VEGF gene The expression of VEGF gene in VSMC showed that pcD2/VEGF Was significantly higher than pcDNA3/VEGF(1103.86 59.49 vs 751.94 208.13 pg/m1/2 105 P 0.05)In vivo experi- ment also showed that the expression of VEGF gene in rats was evident Fourteen days after the initiation of gene therapy histologically identifiable capillaries were increased in VEGF transfectants compared with controls (16.47 0.33 /10 40 P 0.01).The results demonstrated that the ttansfer of VEGF gene stimulated the formation of focal microvessels and pcD 2 /VEGF was better than pcDNA3/VEGF plasmid for VEGF gene therapy
出处 《基础医学与临床》 CSCD 2000年第5期58-60,64,共4页 Basic and Clinical Medicine
关键词 血管内皮生长因子 闭塞性血管病 基因治疗 vascular endothelial growth factot gene exprssion gene therapy peripheral vascular diseases
  • 相关文献

参考文献2

二级参考文献5

  • 1周爱儒 郑卫 等.分子搭桥术-VEGF基因治疗大鼠闭塞性血管病的实验研究[J].中华医学杂志,1996,76:662-666.
  • 2郑卫 霍勇 等.血管内皮生长因子的基因治疗犬闭塞性血管病的初步研究[J].中华心血管病杂志,1998,26:62-64.
  • 3姜志钢,解剖学报,1989年,12卷,142页
  • 4郑卫,中华心血管病杂志,1998年,26卷,62页
  • 5周爱儒,中华医学杂志,1996年,76卷,662页

共引文献156

同被引文献53

  • 1谢传高,王兴鹏,徐选福,蔡建庭,钱可大.选择性环氧合酶2-抑制剂Celebrex对胰腺癌新生血管生成的影响[J].基础医学与临床,2004,24(6):660-663. 被引量:4
  • 2张玉英,丰义宽,李国庆,张居民,孙善明.黏蛋白和血管内皮生长因子在胃癌及癌前病变中的表达及意义[J].中华消化杂志,2005,25(10):628-629. 被引量:2
  • 3LaRochelle WJ, Jeffers M, Corvalan JR, et al. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer[ J]. Cancer Res, 2002, 62 (9) : 2468 - 2473.
  • 4Ustach CV, Taube ME, Hurst NJ Jr, et al. A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression [ J ]. Cancer Res, 2004, 64 ( 5 ) : 1722 - 1729.
  • 5Alakus H, Grass G, Hennecken JK, et al. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer [ J ]. Histol Histopathol, 2008, 23 ( 8 ) : 917 -923.
  • 6Bergsten E, Uutela M, I,i X, et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor [ J ]. Nat Cell Biol, 2001, 3(5) :512 -516.
  • 7Ustach CV, Kim HR. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells [ J ]. Mol Cell Biol, 2005, 25 ( 14 ) : 6279 - 6288.
  • 8Ammoun S, Flaiz C, Ristic N, et al. Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma[J]. Cancer Res, 2008, 68( 13): 5236 - 5245.
  • 9Kong Dejuan, Wang Zhiwei,Sarkar SH, et al. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells[ J]. Stem Cells, 2008, 26(6):1425- 1435.
  • 10Wang Zhiwei, Kong Dejuan, Banerjee S, et al. Down-regulation of platelet derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and Nuclear Factor-KB Signaling[ J]. Cancer Res, 2007, 67(23) :11377 - 11385.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部